Keyphrases
Prostate Cancer
56%
Prostate
39%
Differential Mobility Spectrometry
36%
Magnetic Resonance Imaging
36%
Gleason Score
30%
Population-based
24%
Prostate Cancer Screening
24%
Kallikrein
24%
X-ray
24%
Differential Ion Mobility Spectrometry
24%
Randomized Trial
24%
Androgen Receptor
23%
Prostate-specific Antigen
21%
Breast Cancer
21%
High-grade Prostate Cancer
20%
Pathologist
19%
Classification Accuracy
18%
Tissue Imaging
18%
Prostate Biopsy
16%
Formalin-fixed Paraffin-embedded Tissue
16%
Immunostaining
15%
Clinically Significant Prostate Cancer
15%
Eosin
14%
Screening Trials
14%
Metastasis
13%
Paraffin Blocks
13%
Histology
12%
Autopsy
12%
Whole Slide Image
12%
Magnetic Resonance Imaging-targeted Biopsy
12%
Small Cancer
12%
Dual-color
12%
Antibody Cocktail
12%
Prostate Needle Biopsy
12%
Cancer Cell Populations
12%
Expected Impact
12%
Inter-reader Variability
12%
Breast Tumor
12%
Multi-sampling
12%
Diathermy Smoke
12%
Prostate Cancer Cells
12%
CIP2A
12%
PSA Screening
12%
Origin Tracing
12%
Chromatin Modification
12%
PAXgene
12%
Surgical Pathology
12%
Paraffin-embedded Tissue
12%
Genome Analysis
12%
Tomographic Technique
12%
Medicine and Dentistry
Prostate Cancer
100%
Magnetic Resonance Imaging
49%
Biopsy Technique
44%
Malignant Neoplasm
38%
Gleason Score
34%
Prostate Specific Antigen
29%
Breast Cancer
26%
Personalized Medicine
24%
Kallikrein
24%
Cancer Screening
24%
Spectroscopy
22%
Needle Biopsy
17%
Immunohistochemistry
17%
Prostate Biopsy
17%
Smoke
15%
Diagnosis
14%
Biological Marker
14%
Cancer Growth
14%
Breast Tumor
13%
Cancer Cell
12%
Phosphoprotein Phosphatase 2A
12%
Cell Population
12%
Genome Analysis
12%
Molecular Research
12%
Minichromosome Maintenance Protein 7
12%
Transcription Factor EZH2
12%
Phenomics
12%
Sodium Thiosulfate
12%
Intestine Biopsy
12%
Formaldehyde
12%
Observational Study
12%
Breast Density
12%
Androgen Receptor
12%
Evolution
12%
Diathermy
12%
Field Asymmetric Waveform Ion Mobility Spectrometry
12%
Metastatic Carcinoma
11%
Pathologist
11%
Haematoxylin
9%
Eosin
9%
Breast Tissue
7%
Prostatectomy
7%
Cross-Validation
6%
Breast Carcinoma
6%
Cumulative Incidence
5%
Adipose Tissue
5%
Castration Resistant Prostate Cancer
5%